跳至主要内容
临床试验/NCT01481402
NCT01481402已完成不适用

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Heart Function, Body Composition and Metabolic Status

Jens Faber1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Jens Faber
入组人数
21
试验地点
1
主要终点
left ventricle ejection fraction

研究概览

简要总结

Purpose: The purpose of the study is to examine if treatment with liothyronine increases left ventricular ejection fraction (LVEF) in patients with stable, chronic heart failure.

详细描述

The patients are examined 3 times. At baseline, after 3 months and after 6 months.After the examination is performed, they begin the study medication while admitted at Dept. of Cardiology, Herlev Hospital, for cardiac monitoring.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with stable, chronic systolic heart failure
  • T3 ≤1.4 nmol/l in two blood samples, TSH is to be normal
  • LVEF ≤ 45 % on prior echocardiography

排除标准

  • Established thyroid illness
  • Atrial fibrillation/flutter
  • More than 20% ventricular extrasystoles
  • Severe chronic obstructive lung disorder
  • Pregnancy. Pregnancy testing will be done for fertile women
  • Age < 18 years

研究组 & 干预措施

Placebo-liothyronine

Placebo Comparator

3 months of placebo followed by 3 months of Liothyronine treatment.

干预措施: Liothyronine (Drug)

Liothyronine-Placebo

Other

3 months of Liothyronine treatment followed by 3 months of Placebo treatment.

干预措施: Liothyronine (Drug)

结局指标

主要结局

left ventricle ejection fraction

时间窗: 3 months

The effect of liothyronine treatment in low dose in 3 months on LVEF.

次要结局

  • GDF 8, SHBG, CK and PINP(3 months)
  • Body composition(3 months)
  • Quality of Life, questionaire(3 months)
  • YKL-40, YNF-alpha, hsCRP and IL-6(3 months)
  • RBP 4, HBA1C, adiponectin (high and low weight), glucose and HOMA-1(3 months)
  • NT-proBNP, EDV and ESV(3 months)

研究者

发起方
Jens Faber
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jens Faber

professor

Herlev Hospital

研究点 (1)

Loading locations...

相似试验